Exhibit N

JOINT FILING AGREEMENT

The undersigned hereby agree that the Statement on Schedule 13D, dated August 9, 2010, as amended by Amendment No. 1 to Schedule 13D originally filed on October 4, 2010, Amendment No. 2 to Schedule 13D originally filed on October 22, 2010, Amendment No. 3 to Schedule 13D originally filed on January 13, 2011, Amendment No. 4 to Schedule 13D originally filed on November 23, 2011, Amendment No. 5 to Schedule 13D originally filed on January 9, 2012, and Amendment No. 6 to Schedule 13D filed on November 12, 2013, Amendment No. 7 to Schedule 13D, dated January 23, 2015 (as amended, the “Schedule 13D”), and this Amendment No. 8 to Schedule 13D (“Amendment No. 8”) (including any subsequent amendments, restatements, supplements, and/or exhibits thereto) with respect to the common shares, without par value, of Response Biomedical Corp. was and is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to Amendment No. 8.  Each of the undersigned agrees to be responsible for the timely filing of Amendment No. 8, and for the completeness and accuracy of the information concerning itself contained therein.  This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

Dated:  June 20, 2016	ORBIMED ADVISORS LLC
	By:	/s/ SAMUEL D. ISALY
		Samuel D. Isaly
		Managing Member
	ORBIMED ADVISORS LIMITED
	By:	/s/ SAMUEL D. ISALY
		Samuel D. Isaly
		Director
	ORBIMED ASIA GP, L.P.
	By:	ORBIMED ADVISORS LIMITED, its general partner
	By:	/s/ SAMUEL D. ISALY
		Samuel D. Isaly
		Director
	ORBIMED CAPITAL GP III LLC
	By:	ORBIMED ADVISORS LLC, its managing member
	By:	/s/ SAMUEL D. ISALY
		Samuel D. Isaly
		Managing Member
	SAMUEL D. ISALY
	By:	/s/ SAMUEL D. ISALY
		Samuel D. Isaly